Literature DB >> 11878923

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins.

Stephanie T Shi1, Stephen J Polyak, Hong Tu, Deborah R Taylor, David R Gretch, Michael M C Lai.   

Abstract

The nonstructural protein 5A (NS5A) of the hepatitis C virus (HCV) has been shown to interact with a variety of cellular proteins and implicated in the regulation of cell growth, interferon resistance, and other cellular signaling pathways, but the role of NS5A in HCV pathogenesis has not been firmly established. To further characterize this multifunctional protein, we instigated the studies of the subcellular localization of NS5A in a hepatoma cell line. NS5A was localized to the perinuclear membrane structures, including the endoplasmic reticulum (ER) and the Golgi apparatus, by immunofluorescence staining and confocal microscopy. In addition, it was also associated with the surface of cytoplasmic globular structures when expressed alone or as a part of the NS3-5B polyprotein. Oil red O staining revealed that these globular structures were lipid droplets, where the HCV core protein was also localized. The association of NS5A with intracellular membrane was further confirmed by membrane flotation analysis. To determine whether NS5A interacts with any cellular lipid-binding protein, we performed yeast two-hybrid screening in both HepG2 and human liver cDNA libraries. Apolipoprotein A1 (apoA1), one of the protein components of high-density lipoprotein (HDL) particles, was identified by two independent screening processes. The interaction between NS5A and apoA1 was confirmed by both in vitro pull-down and in vivo coimmunoprecipitation experiments. Immunofluorescence staining revealed a significant colocalization of NS5A and apoA1 in the Golgi apparatus. Our results established an association of NS5A with lipid droplets and apoA1, suggesting that NS5A, together with the core protein, may play a role in the pathogenesis of the derangement of lipid metabolism, contributing to liver steatosis commonly observed in hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11878923     DOI: 10.1006/viro.2001.1225

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  119 in total

1.  Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication.

Authors:  David R Blais; Rodney K Lyn; Michael A Joyce; Yanouchka Rouleau; Rineke Steenbergen; Nicola Barsby; Lin-Fu Zhu; Adrian F Pegoraro; Albert Stolow; David L Tyrrell; John Paul Pezacki
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics.

Authors:  Jinjin Zhang; Jered C Garrison; Larisa Y Poluektova; Tatiana K Bronich; Natalia A Osna
Journal:  Biomaterials       Date:  2015-08-08       Impact factor: 12.479

3.  Functional characterization of core genes from patients with acute hepatitis C virus infection.

Authors:  Xi Tang; Jessica Wagoner; Amina Negash; Michael Austin; John McLauchlan; Young S Hahn; Hugo R Rosen; Stephen J Polyak
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

4.  Steatosis in chronic hepatitis C.

Authors:  M Guidi; P Muratori; A Granito; L Muratori; M Lenzi; F B Bianchi
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

5.  USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.

Authors:  Shinji Kusakabe; Tatsuya Suzuki; Yukari Sugiyama; Saori Haga; Kanako Horike; Makoto Tokunaga; Junki Hirano; He Zhang; David Virya Chen; Hanako Ishiga; Yasumasa Komoda; Chikako Ono; Takasuke Fukuhara; Masahiro Yamamoto; Masahito Ikawa; Takashi Satoh; Shizuo Akira; Tomohisa Tanaka; Kohji Moriishi; Moto Fukai; Akinobu Taketomi; Sachiyo Yoshio; Tatsuya Kanto; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.

Authors:  Thomas Göbel; Sonja Vorderwülbecke; Katarzyna Hauck; Holger Fey; Dieter Häussinger; Andreas Erhardt
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 7.  Steatosis in chronic hepatitis C: why does it really matter?

Authors:  T Asselah; L Rubbia-Brandt; P Marcellin; F Negro
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

8.  Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Authors:  Lance D Presser; Steven McRae; Gulam Waris
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 9.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

10.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.